300 related articles for article (PubMed ID: 20450866)
1. Spasmolytic polypeptide-expressing metaplasia and intestinal metaplasia: time for reevaluation of metaplasias and the origins of gastric cancer.
Goldenring JR; Nam KT; Wang TC; Mills JC; Wright NA
Gastroenterology; 2010 Jun; 138(7):2207-10, 2210.e1. PubMed ID: 20450866
[No Abstract] [Full Text] [Related]
2. Proteomic profiling of paraffin-embedded samples identifies metaplasia-specific and early-stage gastric cancer biomarkers.
Sousa JF; Ham AJ; Whitwell C; Nam KT; Lee HJ; Yang HK; Kim WH; Zhang B; Li M; LaFleur B; Liebler DC; Goldenring JR
Am J Pathol; 2012 Nov; 181(5):1560-72. PubMed ID: 22944598
[TBL] [Abstract][Full Text] [Related]
3. miR-30-HNF4γ and miR-194-NR2F2 regulatory networks contribute to the upregulation of metaplasia markers in the stomach.
Sousa JF; Nam KT; Petersen CP; Lee HJ; Yang HK; Kim WH; Goldenring JR
Gut; 2016 Jun; 65(6):914-24. PubMed ID: 25800782
[TBL] [Abstract][Full Text] [Related]
4. Spasmolytic polypeptide-expressing metaplasia (SPEM) cell lineages can be an origin of gastric cancer.
Goldenring JR
J Pathol; 2023 Jun; 260(2):109-111. PubMed ID: 37145865
[TBL] [Abstract][Full Text] [Related]
5. Amphiregulin-deficient mice develop spasmolytic polypeptide expressing metaplasia and intestinal metaplasia.
Nam KT; Lee HJ; Mok H; Romero-Gallo J; Crowe JE; Peek RM; Goldenring JR
Gastroenterology; 2009 Apr; 136(4):1288-96. PubMed ID: 19230855
[TBL] [Abstract][Full Text] [Related]
6. Association of spasmolytic polypeptide-expressing metaplasia with carcinogen administration and oxyntic atrophy in rats.
Yamaguchi H; Goldenring JR; Kaminishi M; Lee JR
Lab Invest; 2002 Aug; 82(8):1045-52. PubMed ID: 12177243
[TBL] [Abstract][Full Text] [Related]
7. Gastric epithelial stem cells.
Mills JC; Shivdasani RA
Gastroenterology; 2011 Feb; 140(2):412-24. PubMed ID: 21144849
[TBL] [Abstract][Full Text] [Related]
8. Pyloric metaplasia, pseudopyloric metaplasia, ulcer-associated cell lineage and spasmolytic polypeptide-expressing metaplasia: reparative lineages in the gastrointestinal mucosa.
Goldenring JR
J Pathol; 2018 Jun; 245(2):132-137. PubMed ID: 29508389
[TBL] [Abstract][Full Text] [Related]
9. Pyloric, pseudopyloric, and spasmolytic polypeptide-expressing metaplasias in autoimmune gastritis: a case series of 22 Japanese patients.
Wada Y; Nakajima S; Kushima R; Takemura S; Mori N; Hasegawa H; Nakayama T; Mukaisho KI; Yoshida A; Umano S; Yamamoto K; Sugihara H; Murakami K
Virchows Arch; 2021 Jul; 479(1):169-178. PubMed ID: 33515301
[TBL] [Abstract][Full Text] [Related]
10. A molecular signature of gastric metaplasia arising in response to acute parietal cell loss.
Nozaki K; Ogawa M; Williams JA; Lafleur BJ; Ng V; Drapkin RI; Mills JC; Konieczny SF; Nomura S; Goldenring JR
Gastroenterology; 2008 Feb; 134(2):511-22. PubMed ID: 18242217
[TBL] [Abstract][Full Text] [Related]
11. Biology of intestinal metaplasia in 2008: more than a simple phenotypic alteration.
Gutiérrez-González L; Wright NA
Dig Liver Dis; 2008 Jul; 40(7):510-22. PubMed ID: 18400571
[TBL] [Abstract][Full Text] [Related]
12. Metaplasia in the Stomach-Precursor of Gastric Cancer?
Kinoshita H; Hayakawa Y; Koike K
Int J Mol Sci; 2017 Sep; 18(10):. PubMed ID: 28953255
[TBL] [Abstract][Full Text] [Related]
13. Evidence for heightened genetic instability in precancerous spasmolytic polypeptide expressing gastric glands.
Chen J; Zhu C; Wang C; Hu C; Czajkowsky DM; Guo Y; Liu B; Shao Z
J Med Genet; 2020 Jun; 57(6):385-388. PubMed ID: 30877236
[TBL] [Abstract][Full Text] [Related]
14. Expression of trefoil peptides pS2 and human spasmolytic polypeptide in gastric metaplasia at the margin of duodenal ulcers.
Khulusi S; Hanby AM; Marrero JM; Patel P; Mendall MA; Badve S; Poulsom R; Elia G; Wright NA; Northfield TC
Gut; 1995 Aug; 37(2):205-9. PubMed ID: 7557569
[TBL] [Abstract][Full Text] [Related]
15. Spasmolytic polypeptide-expressing metaplasia (SPEM) associated with gastric cancer in Iceland.
Halldórsdóttir AM; Sigurdardóttrir M; Jónasson JG; Oddsdóttir M; Magnússon J; Lee JR; Goldenring JR
Dig Dis Sci; 2003 Mar; 48(3):431-41. PubMed ID: 12757153
[TBL] [Abstract][Full Text] [Related]
16. Three types of metaplasia model through Kras activation, Pten deletion, or Cdh1 deletion in the gastric epithelium.
Kinoshita H; Hayakawa Y; Konishi M; Hata M; Tsuboi M; Hayata Y; Hikiba Y; Ihara S; Nakagawa H; Ikenoue T; Ushiku T; Fukayama M; Hirata Y; Koike K
J Pathol; 2019 Jan; 247(1):35-47. PubMed ID: 30168144
[TBL] [Abstract][Full Text] [Related]
17. Serum Level of Trefoil Factor 2 can Predict the Extent of Gastric Spasmolytic Polypeptide-Expressing Metaplasia in the H. pylori-Infected Gastric Cancer Relatives.
Kuo HY; Chang WL; Yeh YC; Tsai YC; Wu CT; Cheng HC; Yang HB; Lu CC; Sheu BS
Helicobacter; 2017 Feb; 22(1):. PubMed ID: 27220894
[TBL] [Abstract][Full Text] [Related]
18. Special features of intestinal metaplasia and its relation to early gastric carcinoma in man: observation by a method in which leucine aminopeptidase activity is used.
Nakahara K
J Natl Cancer Inst; 1978 Sep; 61(3):693-701. PubMed ID: 278846
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of spasmolytic polypeptide-expressing metaplasia and intestinal metaplasia in Epstein-Barr virus-associated and Epstein-Barr virus-negative gastric cancer.
Zhang Y; Chen JN; Dong M; Zhang ZG; Zhang YW; Wu JY; Du H; Li HG; Huang Y; Shao CK
Hum Pathol; 2017 May; 63():128-138. PubMed ID: 28300576
[TBL] [Abstract][Full Text] [Related]
20. Single-cell transcriptional analyses of spasmolytic polypeptide-expressing metaplasia arising from acute drug injury and chronic inflammation in the stomach.
Bockerstett KA; Lewis SA; Wolf KJ; Noto CN; Jackson NM; Ford EL; Ahn TH; DiPaolo RJ
Gut; 2020 Jun; 69(6):1027-1038. PubMed ID: 31481545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
